Results 191 to 200 of about 491,626 (323)
B Lymphoblastic Lymphoma by Ann Arbor Stage [PDF]
National Cancer Institute
openalex +1 more source
ABSTRACT Background Retinoblastoma (RB) is a malignant eye tumor that predominantly affects children. Although survival rates have improved significantly due to advancements in treatment, subsequent malignant neoplasms (SMNs) continue to be major causes of death in both heritable and non‐heritable RB cases.
Elham Karimi +5 more
wiley +1 more source
Catastrophic asparaginase-induced cerebral and systemic thrombosis in a young female with T-cell lymphoblastic lymphoma: A case report & literature review. [PDF]
Ahmed SAI, AlHanbali AS.
europepmc +1 more source
Non-Hodgkin's lymphoma of T lymphoblastic type of mediastinum and breast, mimicking thymoma
Divakar Bhat, Bhagyashree Jagadeeshwara
openalex +2 more sources
1. Chimeric antigen receptor T (CAR‐T) therapy has made some progress in the treatment of acute myeloid leukaemia (AML), among which C‐type lectin‐like molecule‐1 (CLL1) CAR‐T‐cell therapy has shown certain efficacy in the treatment of relapsed/refractory (R/R) AML. However, 30% of patients exhibit primary treatment resistance. Key factors limiting the
Rui Zhang +3 more
wiley +1 more source
B-cell acute lymphoblastic leukemia and lymphoblastic lymphoma with p190 <i>BCR::ABL1</i> transcript: a case report. [PDF]
Raharjo B +4 more
europepmc +1 more source
Current status and future directions of T‐lymphoblastic lymphoma in children and adolescents
B. Burkhardt +3 more
semanticscholar +1 more source
ABSTRACT Background Chimeric antigen receptor (CAR) T‐cell therapy has revolutionized the treatment of hematological malignancies, offering durable remissions. However, concerns regarding its neurocognitive and psychological impact have emerged, particularly in patients experiencing immune effector cell‐associated neurotoxicity syndrome (ICANS ...
Ashvath Arumugam Pillai +11 more
wiley +1 more source
What's New? Significant advances in childhood cancer survival have transformed outcomes for many children globally. However, emerging evidence suggests that, even in settings with universal healthcare, these gains are not equally distributed. Here, the authors focused on childhood cancer survival in Germany, using data from the German Childhood Cancer ...
Maike Wellbrock +7 more
wiley +1 more source

